How to use the Mounjaro 2.5 mg pen: a step-by-step guide

Each 2.5 mg KwikPen contains four weekly doses — one pen covers your entire first month of treatment.
The injection is subcutaneous: into the fatty layer just beneath the skin, not a vein or muscle.
Three injection sites are licensed: abdomen, upper thigh, and upper arm; rotate the site each week.
The 2.5 mg dose is a tolerability dose, its job is to let your body adjust, not to deliver the full therapeutic effect.

Your first Mounjaro 2.5 mg pen has arrived and you want to get the injection right. The 2.5 mg KwikPen is given as a once-weekly subcutaneous injection into the abdomen, thigh, or upper arm, using the same pen for four consecutive weekly doses. The needle attaches, you press the button, and the pen does the rest. These are prescription-only medicines, so your prescriber will have confirmed the injection technique at the point of clinical approval — but a clear walkthrough is always useful. Here is exactly what to do.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Using the Mounjaro 2.5 mg pen correctly: technique, timing and what to expect

The pen arrives in the post, here is what you do before you even uncap it

Picture this: the DPD box is on the doorstep, you open it, and there is the KwikPen in its foil pouch. Before anything else, it goes straight into the fridge, the door shelf works well, away from the freezer section. Never freeze the pen; frozen pens are unusable and cannot be thawed and reused. Check the packaging for the exact room-temperature window before your first injection, because the SmPC specifies the number of hours the pen can safely sit out and Mounjaro's NHS medicines page for tirzepatide confirms this general principle. If you are taking the pen somewhere (a weekend away, a work trip) keep it in a cool bag rather than a bag left in a warm car.

Choose a fixed day of the week and stick to it. Most people pick a day that fits their routine, such as a Monday evening after dinner or a Friday morning. Consistency matters more than the specific day. You have a roughly 24-hour window either side if life intervenes, but always check the patient information leaflet (PIL) that came with your pen for the exact missed-dose guidance, your prescriber is the right person to call if you are unsure. More detail on what the 2.5 mg pen contains and how it is packaged is on the product page.

The injection itself: step by step with the KwikPen

Wash your hands thoroughly. Remove the pen from the fridge about ten minutes beforehand, injecting cold medicine into the skin is uncomfortable. Gather a new needle (always a fresh one per dose), an alcohol swab, and a sharps bin. Do not shake the pen.

Attach the needle: remove the pen cap, peel the foil from a fresh needle, and twist it onto the pen until it is firmly on. Remove the outer needle cap and set it aside, you will need it to remove the needle safely afterwards. Remove the inner needle cap and discard it. Check the liquid through the window: it should be clear or slightly yellow, with no particles. A small air bubble is normal and harmless.

Clean the chosen skin area with an alcohol swab and let it dry for a few seconds. Pinch the skin lightly if using the abdomen or thigh. Hold the pen at a 90-degree angle, press it firmly against the skin, and press the injection button. Hold it there for a count of ten seconds, this ensures the full dose has been delivered. You may hear a click at the start; that is normal. If you want a full walkthrough before you begin, our step-by-step guide to using the Mounjaro KwikPen 2.5 mg covers every stage from uncapping to disposal. The dose indicator on the pen window will change. Guidance on tracking all four doses across the pen's lifespan explains what to watch for in the window as the pen empties.

After injecting, replace the outer needle cap, unscrew the needle, and dispose of it directly into a sharps bin. Never recap with the inner cap, and never put loose needles in household waste. When it comes to your second dose, the process is identical, same pen, fresh needle, rotated site.

Why 2.5 mg first, and what to expect during your first month

The first pen exists almost entirely to settle your system. At 2.5 mg, most people experience little or no weight change; that is expected and by design. The licensed schedule for tirzepatide starts at this lower strength to reduce the likelihood of nausea, vomiting and other gastrointestinal effects that are more pronounced when higher doses are introduced too quickly. NICE's appraisal of tirzepatide (TA1026) notes the clinical basis for this stepped approach across the full licensed dose range.

Common side effects during the first weeks are mostly gastrointestinal: queasiness, loose stools, constipation or some reflux. These tend to ease within a few days to a couple of weeks as your body adapts. Eating smaller portions, avoiding very fatty or rich meals, and staying well hydrated helps. If symptoms are severe or you develop persistent, intense stomach pain that radiates to your back, seek medical attention promptly, this is the symptom pattern associated with pancreatitis, which is an infrequent but serious side effect the MHRA has flagged for all GLP-1 medicines.

After four weekly doses on 2.5 mg, your prescriber will review your tolerance and progress before any dose change. No adjustment happens automatically, a real clinician looks at your case before each repeat. If you have questions about what happens at titration, understanding the concept of the golden dose sets out how patients find their longer-term maintenance level. For context on the broader treatment journey, the mounjaro overview page covers how the medicine works and what the evidence shows across the full programme. And if you are still deciding whether to start, checking your eligibility with our prescribers costs nothing and takes a few minutes.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions